Incorporating Supramaximal Resection into Survival Stratification of IDH-Wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis

Central Nervous System Tumors

Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM

Neuro Oncol

Massaad E, Smith WJ, Bradley J, Esposito E, Gupta M, Burns E, Burns R, Velarde JK, Berglar IK, Gupta R, Martinez-Lage M, Dietrich J, Lennerz JK, Dunn GP, Jones PS, Choi BD, Kim AE, Frosch M, Barker FG 2nd, Curry WT, Carter BS, Nahed BV, Cahill DP, Shankar GM

doi: 10.1093/neuonc/noae073

Central Nervous System Tumors

Leptomeningeal Metastases in IDH-wildtype Glioblastomas Revisited: Comprehensive Analysis of Incidence, Risk Factors, and Prognosis Based on Post-contrast FLAIR

Neuro Oncol

Park YW, Jang G, Kim SB, Choi K, Han K, Shin NY, Ahn SS, Chang JH, Kim SH, Lee SK, Jain R

doi: 10.1093/neuonc/noae091

Central Nervous System Tumors

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas

Neuro Oncol

Kinslow CJ, Roy S, Iwamoto FM, Brown PD, DeStephano DM, Canoll PD, Qureshi SS, Gallito M, Sisti MB, Bruce JN, Horowitz DP, Kachnic LA, Neugut AI, Yu JB, Mehta MP, Cheng SK, Wang TJC

doi: 10.1093/neuonc/noae102

Gastrointestinal Cancer

Increased Occurrence of Malignancy Before and after Chemoradiation for Anal Squamous Cell Carcinoma: A Multi-Institutional Analysis

J Natl Cancer Inst

Kumar R, Hallemeier CL, Chang DT, Lu SE, Hathout L, Hristidis VC, Jethwa KR, Baclay JRM, Manne V, Chakrani Z, Haddock MG, Toesca DAS, Pollom EL, Wu AJ, Sandhyavenu H, Romesser PB, Jabbour SK

doi: 10.1093/jnci/djae309

Radio-Oncology

Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation

Lancet Oncol

Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O

doi: 10.1016/S1470-2045(24)00148-7

Lung, Respiratory and Thoracic Cancer

Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis

J Thorac Oncol

Marinelli D, Nuccio A, Di Federico A, Ambrosi F, Bertoglio P, Faccioli E, Ferrara R, Ferro A, Giusti R, Guerrera F, Mammana M, Pittaro A, Sepulcri M, Viscardi G, Gallina FT

doi: 10.1016/j.jtho.2024.09.1443

Skin Cancer

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study

J Clin Oncol

Luke JJ, Ascierto PA, Khattak MA, de la Cruz Merino L, Del Vecchio M, Rutkowski P, Spagnolo F, Mackiewicz J, Chiarion-Sileni V, Kirkwood JM, Robert C, Grob JJ, de Galitiis F, Schadendorf D, Carlino MS, Wu XL, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Long GV

doi: 10.1200/JCO.23.02355

Leukemia

NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients

Blood

Simonin M, Vasseur L, Lengliné E, Lhermitte L, Cabannes-Hamy A, Balsat M, Schmidt A, Dourthe ME, Touzart A, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Rigal-Huguet F, Ducassou S, Lheritier V, Chalandon Y, Ifrah N, Dombret H, Macintyre EA, Petit A, Rousselot P, Lambert J, Baruchel A, Boissel N, Asnafi V

doi: 10.1182/blood.2023023754

Further Publications

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis

Lancet Oncol

Naci H, Zhang Y, Woloshin S, Guan X, Xu Z, Wagner AK

doi: 10.1016/S1470-2045(24)00152-9

Related content

Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM

Leptomeningeal Metastases in IDH-wildtype Glioblastomas Revisited: Comprehensive Analysis of Incidence, Risk Factors, and Prognosis Based on Post-contrast FLAIR

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas

Increased Occurrence of Malignancy Before and after Chemoradiation for Anal Squamous Cell Carcinoma: A Multi-Institutional Analysis

Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation

Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study

NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis